CatalYm
CatalYm is an innovative immunotherapies developer for cancer patients founded in 2016.
2
Funding Rounds
$160.0m
Money raised
Overview
CatalYm is an innovative immunotherapies developer for cancer patients founded in 2016.
- Website:
- Business model: B2B
- Headquarters: Munich
- Social accounts: linkedin
Funding series
Funding Series Analysis
The company CatalYm has raised a total of $59m in funding over 2 rounds.
Key Insights:
- CataIYm Series B round, November 2020: $59m
- CataIYm Series C round, November 22, 2022: $49m
CataIYm Series B round, November 2020
$59m
CataIYm Series C round, November 22, 2022
$49m
Industries
CatalYm is active in the following industries: